NCT00148148 A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation Status COMPLETED Phase PHASE2
NCT00145080 Comparison of Osteoporosis Disease Management Strategies (0000-039) Status COMPLETED Phase NA
NCT00145067 Osteoporosis Disease Management Demonstration Project (0000-040) Status COMPLETED Phase NA
NCT00142298 Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies Status COMPLETED Phase PHASE3
NCT00140933 A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome Status TERMINATED Phase PHASE3
NCT00140920 A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259) Status TERMINATED Phase PHASE4
NCT00140894 A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED) Status TERMINATED Phase PHASE4
NCT00139932 Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) Status COMPLETED Phase PHASE4
NCT00139438 Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038) Status COMPLETED Phase NA
NCT00139425 Osteoporosis Disease Management Demonstration Project (0000-037) Status COMPLETED Phase NA
NCT00135655 A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema Status WITHDRAWN Phase PHASE2
NCT00134303 Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity Status COMPLETED Phase PHASE4
NCT00132912 Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573) Status COMPLETED Phase PHASE2
NCT00132769 A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00132730 An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005) Status TERMINATED Phase PHASE2
NCT00131430 An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED) Status COMPLETED Phase PHASE2/PHASE3
NCT00131404 A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED) Status TERMINATED Phase PHASE3